Español | English
ISSN: 0210-0576 
e-ISSN: 1698-7624 
Subscribers area
Home Editorial Board Journal Contents Subscriptions Contact Us Authors Instructions
<<< back |
Original Article

Bisphosphonates and orthodontics

2009, Volumen 39, Número 3
Javier Mareque Bueno, Jordi García Linares, Josep Rubio Palau
Profesor Departamento Patología Médico-Quirúrgica e Implantología. Universidad Internacional de Cataluña. Servicio de Cirugía Oral y Maxilofacial. Hospital Vall d’Hebron. Barcelona. Instituto de Cirugía Maxilofacial e Implantología. Centro Médico Teknon. Barcelona

Bisphosphonates are used worldwide as inhibitors of bone resorption in several pathologies. Bisphosphonates can be administrated orally or intravenously. Oral bisphosphonates are mainly used to stop bone loss in osteoporosis. Intravenous are used for bone metastases on malignancy. Scientific societies have defined diagnostic criteria and the risk factors for developing the osteonecrosis which are in constant review. Among dental specialties orthodontics is the less affected by this new problem, which was initially notified by maxillofacial surgeons, and is this specialty the one who mainly have to deal with it because principally it appears after dentoalveolar surgery. Several secondary effects have been notified because of the use of oral bisphosphonates so as smaller tooth movement and osteonecrosis of the jaws. In this paper we show the recommendations addressed in the recent literature for the management of orthodontics in patients taking bisphosphonates.  (Rev Esp Ortod. 2009;39(3):213-220)

Key words:
Bisphosphonates. Orthodontics. Bone necrosis jaws.
[Buy article]
Mallorca, 310 - 08037 Barcelona - Spain
Phone: +34 93 207 59 20
Fax: +34 93 457 66 42
  © Permanyer Publications | Made & Powered by IMMA PUIG | Privacy Policy | Legal notice